Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

It's called financial analysis but you can refer to it as Debbie Downer shtick if you like. Such shtick comes about as a result of Downer financials....I know it's difficult for you to avoid but there's nothing to be gained by shooting a messenger of facts.

"This discussion about finances came out in the 10Q. You were doing your Debbie Downer shtick before then."
That's because it actually came out in the 10K, not the 10Q. Of course one would have to have read the 10K to know that.

And I won't be deterred from repeating it because it's important:
"The principal executive officer and principal financial officer of the Company (that's just one guy in this company) has concluded that the Company’s disclosure controls and procedures are not effective due to the material weakness in the Company’s internal control over financial reporting as of June 30, 2023 as described in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023."
"If we fail to properly remediate this or any future material weakness or deficiencies, our ability to produce accurate and timely financial statements may be impaired."
"This material weakness could result in a misstatement of the recorded equity investment as well as the equity in loss from equity investment that would not be prevented or detected on a timely basis."

No serious investor would downplay the importance of a CEO's conclusion, especially considering that the CEO is a CPA, that his Company’s disclosure controls and procedures are not effective. And no serious investor would buy the shares of such a Company, certainly no institutional investor would.